Authors argue against the adoption of time-in-tight range (70-140mg/dL) in type 1 diabetes.
diabetesjournals.org/care/article/4…

But there is nuance...
1) 70-140 is clearly more physiologic.
2) Dose response data suggest lower HbA1c improves outcomes acroas many metrics.
3) However, as even

Being pro medicine doesn’t mean you’re anti lifestyle.

Also vice versa.

Very fortunate to be given this tremendous platform to do the Lord’s work (trying to convince more people to watch Tokyo Vice) 🫡

Digital diabetes care vendors are in crisis management mode as people realize their clinical research is underwhelming but they are far more costly than usual care.

Only Virta has clinical outcomes that reliably exceed usual care (although no RCT).
axios.com/pro/health-tec…

a call for increaesd interoperabilty between devices as well as between devices and electronic health records
Nick Oliver Julia Mader 🇺🇦🇦🇹🏳️‍🌈🇪🇺🇮🇱 DovcK David Klonoff 🌱Leicester Diabetes Diabetes Technology Network UK DTN-UK EASD
ncbi.nlm.nih.gov/pmc/articles/P…

Calling innovators: Don't miss the chance to apply to the American Diabetes Association's #DiabetesInnovationChallenge , which will happen onstage at the ADA’s Scientific Sessions this summer! Deadline for applications coming up soon: March 15th. professional.diabetes.org/scientific-ses…

Shower thought: priority for emergency exit row seats on airplanes should be given to people who have demonstrated service to the community (eg. Military, First Responders, etc). “Being willing to pay extra for more legroom” doesn’t inspire as much confidence…

Advanced Technologies & Treatments for Diabetes DSNforumUK Diabetes Technology Network UK DTN-UK Alistair Baxter

Dr. Pettus explained the common problem of insulin resistance in #type1diabetes . He summarized the potential solutions and detailed our study results published Nature Medicine of glucagon receptor antagonist use in #type1diabetes . #ATTD2024

Here's my hot off the press top 10 takeaways from my time at #ATTD2024 with the #dedoc voices. Longer post to follow on the blog (probably tomorrow). Thanks to #dedoc° for the opportunity to attend and lovely to spend time with the other #dedoc voices.

I was today years old when I learned Europe changes their clocks for daylight savings time on different days than they do in the USA. That means I don't have to 'spring forward' this year! Woohoo! #ATTD2024

We should insist that all once weekly insulin pens be “connected” or have a way to help patients remember if/when they took their dose. #attd2024 #t1d #t2d

Dr. Shah showed the results of our recent study to use #tirzepatide , a dual GIP/GLP1 agonists in people with #obesity and #type1diabetes . Great improvements in A1c, TIR and TITR and decrease in insulin use. More study results will follow in ADA. #ATTD2024

Dr. Hirsch summarized the important use of GMI and differences in glycation that may explain the differences between GMI and A1c. In a counter argument Liz Selvin explained the better use of A1c over GMI. #ATTD2024

Nat’s Pancreas 404 🐝 #DavosSafe Advanced Technologies & Treatments for Diabetes #dedoc° The_dia_being_mindset Boris Kovatchev presenting on 'Neural-Net artificial pancreas'

The objective was to introduce a new regulatory and clinical paradigm - a Neural-Net Artificial Pancreas (NAP) - an encoding of an AID algorithm into a neural network that approximates its action)

#dedoc #ATTD2024

#Accuchek #SmartGuide CGM was just announced with: 1) a traditional CGM app, AND 2) the Smartguide Predict app #ATTD2024 #t1d

- 14 day wear
- MARD 9.2%
- Apple Watch connectivity
- 2 hr glucose prediction curve
- 30 min low prediction
- Night low prediction

'Optimally supporting a person with #diabetes is about the entire patient experience and not simply their glycemic performance.' - David Ahn, MD re new Endocrine Society statement #medtwitter medscape.com/viewarticle/st…

#WomenInScience Happy to share our first paper with an all-female author group Ingrid Schuetz Österreichische Diabetes Gesellschaft EASD Med Uni Graz MedUni Wien Advanced Technologies & Treatments for Diabetes

I officially propose that we end the 'I know I'm standing between you and lunch/break/end of the day' comment that speakers always make at every conference. (I'm guilty of this too).

So... #KansasCityChiefs player Noah Gray has #type1diabetes , as do one of the children of Usher who's doing the #HalfTimeShow and one of Taylor Swift's best friends, Este Haim. And maybe new #Dexcom ads with Nick Jonas? Not that I'm keeping score...😄🏈 #SuperBowl #T1D